The pan-JAK inhibitor LAS194046 reduces neutrophil activation from severe asthma and COPD patients in vitro

Non-T2 severe asthma and chronic obstructive pulmonary disease (COPD) are airway chronic inflammatory disorders with a poor response to corticosteroids. LAS194046, a novel pan-Janus kinase (JAK) inhibitor, shows inhibitory effects on T2 allergic lung inflammation in rats. In this work we analyze the...

Descripción completa

Detalles Bibliográficos
Autores principales: Milara, Javier, Ballester, Beatriz, de Diego, Alfredo, Calbet, Marta, Ramis, Isabel, Miralpeix, Montserrat, Cortijo, Julio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948298/
https://www.ncbi.nlm.nih.gov/pubmed/35332239
http://dx.doi.org/10.1038/s41598-022-09241-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948298/
https://www.ncbi.nlm.nih.gov/pubmed/35332239
http://dx.doi.org/10.1038/s41598-022-09241-6

Ejemplares similares